| 1 | ACAD | ACADIA Pharmaceuticals Inc. | 4.77% |
| 2 | NBIX | Neurocrine Biosciences, Inc. | 4.36% |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.19% |
| 4 | ILMN | Illumina, Inc. | 3.94% |
| 5 | INCY | Incyte Corporation | 3.90% |
| 6 | EXEL | Exelixis, Inc. | 3.82% |
| 7 | EXAS | Exact Sciences Corporation | 3.65% |
| 8 | MTD | Mettler-Toledo International Inc. | 3.58% |
| 9 | NTRA | Natera, Inc. | 3.55% |
| 10 | ONC | BeOne Medicines Ltd. | 3.46% |
| 11 | GMAB | Genmab A/S | 3.45% |
| 12 | BIIB | Biogen Inc. | 3.45% |
| 13 | BNTX | BioNTech SE | 3.44% |
| 14 | WAT | Waters Corporation | 3.41% |
| 15 | BRKR | Bruker Corporation | 3.40% |
| 16 | CORT | Corcept Therapeutics Incorporated | 3.39% |
| 17 | ALKS | Alkermes plc | 3.34% |
| 18 | MRNA | Moderna, Inc. | 3.29% |
| 19 | GILD | Gilead Sciences, Inc. | 3.25% |
| 20 | RGEN | Repligen Corporation | 3.16% |
| 21 | UTHR | United Therapeutics Corporation | 3.16% |
| 22 | AMGN | Amgen Inc. | 3.05% |
| 23 | ARGX | argenx SE | 3.02% |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 2.98% |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 2.94% |
| View FBT holdings |